102 related articles for article (PubMed ID: 8095402)
1. The cytochrome P450 1A2 active site: topology and perturbations caused by glutamic acid-318 and threonine-319 mutations.
Tuck SF; Hiroya K; Shimizu T; Hatano M; Ortiz de Montellano PR
Biochemistry; 1993 Mar; 32(10):2548-53. PubMed ID: 8095402
[TBL] [Abstract][Full Text] [Related]
2. Active site topology of Saccharomyces cerevisiae lanosterol 14 alpha-demethylase (CYP51) and its G310D mutant (cytochrome P-450SG1).
Tuck SF; Aoyama Y; Yoshida Y; Ortiz de Montellano PR
J Biol Chem; 1992 Jul; 267(19):13175-9. PubMed ID: 1618820
[TBL] [Abstract][Full Text] [Related]
3. Active site topology of human cytochrome P450 2E1.
Mackman R; Guo Z; Guengerich FP; Ortiz de Montellano PR
Chem Res Toxicol; 1996; 9(1):223-6. PubMed ID: 8924594
[TBL] [Abstract][Full Text] [Related]
4. Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutants.
Mackman R; Tschirret-Guth RA; Smith G; Hayhurst GP; Ellis SW; Lennard MS; Tucker GT; Wolf CR; Ortiz de Montellano PR
Arch Biochem Biophys; 1996 Jul; 331(1):134-40. PubMed ID: 8660692
[TBL] [Abstract][Full Text] [Related]
5. Active sites of the cytochrome p450cam (CYP101) F87W and F87A mutants. Evidence for significant structural reorganization without alteration of catalytic regiospecificity.
Tuck SF; Graham-Lorence S; Peterson JA; Ortiz de Montellano PR
J Biol Chem; 1993 Jan; 268(1):269-75. PubMed ID: 8416934
[TBL] [Abstract][Full Text] [Related]
6. Active site topologies of bacterial cytochromes P450101 (P450cam), P450108 (P450terp), and P450102 (P450BM-3). In situ rearrangement of their phenyl-iron complexes.
Tuck SF; Peterson JA; Ortiz de Montellano PR
J Biol Chem; 1992 Mar; 267(8):5614-20. PubMed ID: 1544935
[TBL] [Abstract][Full Text] [Related]
7. Topological mapping of the active sites of cytochromes P4502B1 and P4502B2 by in situ rearrangement of aryl-iron complexes.
Tuck SF; Ortiz de Montellano PR
Biochemistry; 1992 Aug; 31(30):6911-6. PubMed ID: 1637824
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of Glu318 and Thr319 in cytochrome P450 1A2 catalysis supported by NADPH-cytochrome P450 reductase and tert-butyl hydroperoxide.
Hiroya K; Murakami Y; Shimizu T; Hatano M; Ortiz de Montellano PR
Arch Biochem Biophys; 1994 May; 310(2):397-401. PubMed ID: 7910007
[TBL] [Abstract][Full Text] [Related]
9. Topological changes in the CYP3A4 active site probed with phenyldiazene: effect of interaction with NADPH-cytochrome P450 reductase and cytochrome b5 and of site-directed mutagenesis.
Yamaguchi Y; Khan KK; He YA; He YQ; Halpert JR
Drug Metab Dispos; 2004 Jan; 32(1):155-61. PubMed ID: 14709633
[TBL] [Abstract][Full Text] [Related]
10. Chiral recognition at cytochrome P450 1A2 active site: effects of mutations at the putative distal site on the bindings of asymmetrical axial ligands.
Krainev AG; Shimizu T; Ishigooka M; Hiroya K; Hatano M
Biochemistry; 1993 Mar; 32(8):1951-7. PubMed ID: 8448154
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
12. Effect of mutations of ionic amino acids of cytochrome P450 1A2 on catalytic activities toward 7-ethoxycoumarin and methanol.
Mayuzumi H; Sambongi C; Hiroya K; Shimizu T; Tateishi T; Hatano M
Biochemistry; 1993 Jun; 32(21):5622-8. PubMed ID: 8504082
[TBL] [Abstract][Full Text] [Related]
13. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.
Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP
Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105
[TBL] [Abstract][Full Text] [Related]
14. Glu318 and Thr319 mutations of cytochrome P450 1A2 remarkably enhance homolytic O-O cleavage of alkyl hydroperoxides. An optical absorption spectral study.
Shimizu T; Murakami Y; Hatano M
J Biol Chem; 1994 May; 269(18):13296-304. PubMed ID: 7909807
[TBL] [Abstract][Full Text] [Related]
15. Topological analysis of the active sites of cytochromes P450IIB4 (rabbit), P450IIB10 (mouse), and P450IIB11 (dog) by in situ rearrangement of phenyl-iron complexes.
Swanson BA; Halpert JR; Bornheim LM; Ortiz de Montellano PR
Arch Biochem Biophys; 1992 Jan; 292(1):42-6. PubMed ID: 1727649
[TBL] [Abstract][Full Text] [Related]
16. Conserved Glu318 at the cytochrome P450 1A2 distal site is crucial in the nitric oxide complex stability.
Nakano R; Sato H; Watanabe A; Ito O; Shimizu T
J Biol Chem; 1996 Apr; 271(15):8570-4. PubMed ID: 8621484
[TBL] [Abstract][Full Text] [Related]
17. The active sites of cytochromes P450 IA1, IIB1, IIB2, and IIE1. Topological analysis by in situ rearrangement of phenyl-iron complexes.
Swanson BA; Dutton DR; Lunetta JM; Yang CS; Ortiz de Montellano PR
J Biol Chem; 1991 Oct; 266(29):19258-64. PubMed ID: 1918043
[TBL] [Abstract][Full Text] [Related]
18. Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl.
Yun CH; Hammons GJ; Jones G; Martin MV; Hopkins NE; Alworth WL; Guengerich FP
Biochemistry; 1992 Nov; 31(43):10556-63. PubMed ID: 1420171
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the reduction of cytochrome b5 with mutations in its membrane-binding domain.
Wu FF; Vergères G; Waskell L
Arch Biochem Biophys; 1994 Feb; 308(2):380-6. PubMed ID: 7906503
[TBL] [Abstract][Full Text] [Related]
20. Essential role of His163 of cytochrome P450 1A2 in catalytic functions associated with cytochrome b5.
Mayuzumi H; Shimizu T; Sambongi C; Hiroya K; Hatano M
Arch Biochem Biophys; 1994 May; 310(2):367-72. PubMed ID: 8179321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
